Organisation Overview
The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium.
Our Mission
Improving cancer Patient Survival and Quality of Life – at the heart of EORTC’s research, since 1962.
Our Impact
Enabling and Delivering on Practice-Changing Clinical Cancer Research since 1962.
Annual Report
Latest EORTC Press Releases
PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation
27 Jun 2022
MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression
17 Mar 2022
PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
29 Jun 2021
PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
4 Jun 2021
EORTC in the News/Press
EORTC Media Assets
Showcase the EORTC with the right logos and assets:
EORTC profile
The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium.
For further information, please visit www.eortc.org.
EORTC Imagery
Media Relations Contact Information
Our Communications team loves working with journalists to share compelling stories about cancer research and care. If you are a member of the media and would like to reach out, please send an email to communication@eortc.org.
